APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parenteral PrEP

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Parenteral PrEP Market Analysis and Forecast 2026-2032

29 December 2025196 pages

Choose your research edition.

Industry ResearchParenteral PrEP Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral PrEP Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Parenteral PrEP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral PrEP Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral PrEP Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Parenteral PrEP market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Parenteral PrEP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Parenteral PrEP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Parenteral PrEP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Parenteral PrEP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Parenteral PrEP include Gilead Sciences and ViiV Healthcare etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Parenteral PrEP, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Parenteral PrEP, also provides the sales of main regions and countries. Of the upcoming market potential for Parenteral PrEP, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Parenteral PrEP sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Parenteral PrEP market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Parenteral PrEP sales, projected growth trends, production technology, application and end-user industry.

Parenteral PrEP Segment by Company

Gilead Sciences

ViiV Healthcare

Parenteral PrEP Segment by Type

Cabotegravir

Lenacapavir

Other

Parenteral PrEP Segment by Application

Subcutaneous Use

Intramuscular Use

Parenteral PrEP Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral PrEP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral PrEP and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral PrEP.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Parenteral PrEP in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Parenteral PrEP manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parenteral PrEP sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Parenteral PrEP Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cabotegravir Major Manufacturers Table 3. Lenacapavir Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Parenteral PrEP Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Subcutaneous Use Major Manufacturers Table 7. Intramuscular Use Major Manufacturers Table 8. Parenteral PrEP Industry Trends Table 9. Parenteral PrEP Industry Drivers Table 10. Parenteral PrEP Industry Opportunities and Challenges Table 11. Parenteral PrEP Industry Restraints Table 12. Global Parenteral PrEP Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Parenteral PrEP Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Parenteral PrEP Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Parenteral PrEP Revenue Market Share by Region (2021-2026) Table 16. Global Parenteral PrEP Revenue Market Share by Region (2027-2032) Table 17. Global Parenteral PrEP Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Parenteral PrEP Sales by Region (2021-2026) & (K Units) Table 19. Global Parenteral PrEP Sales by Region (2027-2032) & (K Units) Table 20. Global Parenteral PrEP Sales Market Share by Region (2021-2026) Table 21. Global Parenteral PrEP Sales Market Share by Region (2027-2032) Table 22. Global Parenteral PrEP Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Parenteral PrEP Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Parenteral PrEP Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Parenteral PrEP Sales Market Share by Manufacturers (2021-2026) Table 26. Global Parenteral PrEP Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Parenteral PrEP Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Parenteral PrEP Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Parenteral PrEP Manufacturers, Product Type & Application Table 30. Global Parenteral PrEP Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Parenteral PrEP by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Parenteral PrEP Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Parenteral PrEP Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Parenteral PrEP Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Parenteral PrEP Revenue Market Share by Type (2021-2026) Table 37. Global Parenteral PrEP Revenue Market Share by Type (2027-2032) Table 38. Global Parenteral PrEP Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 40. Global Parenteral PrEP Sales by Type (2027-2032) & (K Units) Table 41. Global Parenteral PrEP Sales Market Share by Type (2021-2026) Table 42. Global Parenteral PrEP Sales Market Share by Type (2027-2032) Table 43. Global Parenteral PrEP Price by Type (2021-2026) & (US$/Unit) Table 44. Global Parenteral PrEP Price by Type (2027-2032) & (US$/Unit) Table 45. Global Parenteral PrEP Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Parenteral PrEP Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Parenteral PrEP Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Parenteral PrEP Revenue Market Share by Application (2021-2026) Table 49. Global Parenteral PrEP Revenue Market Share by Application (2027-2032) Table 50. Global Parenteral PrEP Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 52. Global Parenteral PrEP Sales by Application (2027-2032) & (K Units) Table 53. Global Parenteral PrEP Sales Market Share by Application (2021-2026) Table 54. Global Parenteral PrEP Sales Market Share by Application (2027-2032) Table 55. Global Parenteral PrEP Price by Application (2021-2026) & (US$/Unit) Table 56. Global Parenteral PrEP Price by Application (2027-2032) & (US$/Unit) Table 57. Gilead Sciences Company Information Table 58. Gilead Sciences Business Overview Table 59. Gilead Sciences Parenteral PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Gilead Sciences Parenteral PrEP Product Portfolio Table 61. Gilead Sciences Recent Development Table 62. ViiV Healthcare Company Information Table 63. ViiV Healthcare Business Overview Table 64. ViiV Healthcare Parenteral PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. ViiV Healthcare Parenteral PrEP Product Portfolio Table 66. ViiV Healthcare Recent Development Table 67. North America Parenteral PrEP Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Parenteral PrEP Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 70. North America Parenteral PrEP Sales by Type (2027-2032) & (K Units) Table 71. North America Parenteral PrEP Sales Price by Type (2021-2026) & (US$/Unit) Table 72. North America Parenteral PrEP Sales Price by Type (2027-2032) & (US$/Unit) Table 73. North America Parenteral PrEP Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Parenteral PrEP Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 76. North America Parenteral PrEP Sales by Application (2027-2032) & (K Units) Table 77. North America Parenteral PrEP Sales Price by Application (2021-2026) & (US$/Unit) Table 78. North America Parenteral PrEP Sales Price by Application (2027-2032) & (US$/Unit) Table 79. North America Parenteral PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Parenteral PrEP Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Parenteral PrEP Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Parenteral PrEP Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 83. North America Parenteral PrEP Sales by Country (2021-2026) & (K Units) Table 84. North America Parenteral PrEP Sales by Country (2027-2032) & (K Units) Table 85. North America Parenteral PrEP Sales Price by Country (2021-2026) & (US$/Unit) Table 86. North America Parenteral PrEP Sales Price by Country (2027-2032) & (US$/Unit) Table 87. United States Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 88. Canada Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 89. Mexico Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 90. Europe Parenteral PrEP Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Parenteral PrEP Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 93. Europe Parenteral PrEP Sales by Type (2027-2032) & (K Units) Table 94. Europe Parenteral PrEP Sales Price by Type (2021-2026) & (US$/Unit) Table 95. Europe Parenteral PrEP Sales Price by Type (2027-2032) & (US$/Unit) Table 96. Europe Parenteral PrEP Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Parenteral PrEP Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 99. Europe Parenteral PrEP Sales by Application (2027-2032) & (K Units) Table 100. Europe Parenteral PrEP Sales Price by Application (2021-2026) & (US$/Unit) Table 101. Europe Parenteral PrEP Sales Price by Application (2027-2032) & (US$/Unit) Table 102. Europe Parenteral PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Parenteral PrEP Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Parenteral PrEP Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Parenteral PrEP Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 106. Europe Parenteral PrEP Sales by Country (2021-2026) & (K Units) Table 107. Europe Parenteral PrEP Sales by Country (2027-2032) & (K Units) Table 108. Europe Parenteral PrEP Sales Price by Country (2021-2026) & (US$/Unit) Table 109. Europe Parenteral PrEP Sales Price by Country (2027-2032) & (US$/Unit) Table 110. Germany Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 111. France Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 112. U.K. Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 113. Italy Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 114. Russia Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 115. Spain Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 118. Sweden Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 119. Poland Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 120. China Parenteral PrEP Revenue by Type (2021-2026) & (US$ Million) Table 121. China Parenteral PrEP Revenue by Type (2027-2032) & (US$ Million) Table 122. China Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 123. China Parenteral PrEP Sales by Type (2027-2032) & (K Units) Table 124. China Parenteral PrEP Sales Price by Type (2021-2026) & (US$/Unit) Table 125. China Parenteral PrEP Sales Price by Type (2027-2032) & (US$/Unit) Table 126. China Parenteral PrEP Revenue by Application (2021-2026) & (US$ Million) Table 127. China Parenteral PrEP Revenue by Application (2027-2032) & (US$ Million) Table 128. China Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 129. China Parenteral PrEP Sales by Application (2027-2032) & (K Units) Table 130. China Parenteral PrEP Sales Price by Application (2021-2026) & (US$/Unit) Table 131. China Parenteral PrEP Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Asia Parenteral PrEP Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Parenteral PrEP Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 135. Asia Parenteral PrEP Sales by Type (2027-2032) & (K Units) Table 136. Asia Parenteral PrEP Sales Price by Type (2021-2026) & (US$/Unit) Table 137. Asia Parenteral PrEP Sales Price by Type (2027-2032) & (US$/Unit) Table 138. Asia Parenteral PrEP Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Parenteral PrEP Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 141. Asia Parenteral PrEP Sales by Application (2027-2032) & (K Units) Table 142. Asia Parenteral PrEP Sales Price by Application (2021-2026) & (US$/Unit) Table 143. Asia Parenteral PrEP Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia Parenteral PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Parenteral PrEP Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Parenteral PrEP Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Parenteral PrEP Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 148. Asia Parenteral PrEP Sales by Country (2021-2026) & (K Units) Table 149. Asia Parenteral PrEP Sales by Country (2027-2032) & (K Units) Table 150. Asia Parenteral PrEP Sales Price by Country (2021-2026) & (US$/Unit) Table 151. Asia Parenteral PrEP Sales Price by Country (2027-2032) & (US$/Unit) Table 152. Japan Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 153. South Korea Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 154. India Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 155. Australia Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Parenteral PrEP Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Parenteral PrEP Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 161. SAMEA Parenteral PrEP Sales by Type (2027-2032) & (K Units) Table 162. SAMEA Parenteral PrEP Sales Price by Type (2021-2026) & (US$/Unit) Table 163. SAMEA Parenteral PrEP Sales Price by Type (2027-2032) & (US$/Unit) Table 164. SAMEA Parenteral PrEP Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Parenteral PrEP Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 167. SAMEA Parenteral PrEP Sales by Application (2027-2032) & (K Units) Table 168. SAMEA Parenteral PrEP Sales Price by Application (2021-2026) & (US$/Unit) Table 169. SAMEA Parenteral PrEP Sales Price by Application (2027-2032) & (US$/Unit) Table 170. SAMEA Parenteral PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Parenteral PrEP Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Parenteral PrEP Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Parenteral PrEP Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. SAMEA Parenteral PrEP Sales by Country (2021-2026) & (K Units) Table 175. SAMEA Parenteral PrEP Sales by Country (2027-2032) & (K Units) Table 176. SAMEA Parenteral PrEP Sales Price by Country (2021-2026) & (US$/Unit) Table 177. SAMEA Parenteral PrEP Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Brazil Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 179. Argentina Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 180. Chile Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 181. Colombia Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 182. Peru Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 184. Israel Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 185. UAE Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 186. Turkey Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 187. Iran Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 188. Egypt Parenteral PrEP Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Parenteral PrEP Distributors List Table 192. Parenteral PrEP Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Parenteral PrEP Image Figure 2. Global Parenteral PrEP Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral PrEP Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cabotegravir Image Figure 5. Lenacapavir Image Figure 6. Other Image Figure 7. Global Parenteral PrEP Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Parenteral PrEP Market Size Share 2021 VS 2025 VS 2032 Figure 9. Subcutaneous Use Image Figure 10. Intramuscular Use Image Figure 11. Global Parenteral PrEP Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Parenteral PrEP Revenue (2021-2032) & (US$ Million) Figure 13. Global Parenteral PrEP Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Parenteral PrEP Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Parenteral PrEP Revenue Market Share by Region (2021-2032) Figure 16. Global Parenteral PrEP Sales (2021-2032) & (K Units) Figure 17. Global Parenteral PrEP Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Parenteral PrEP Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Parenteral PrEP Sales YoY (2021-2032) & (K Units) Figure 20. Europe Parenteral PrEP Sales YoY (2021-2032) & (K Units) Figure 21. China Parenteral PrEP Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Parenteral PrEP Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Parenteral PrEP Sales YoY (2021-2032) & (K Units) Figure 24. Global Parenteral PrEP Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Parenteral PrEP Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Parenteral PrEP Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Parenteral PrEP Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Parenteral PrEP Revenue Market Share by Type (2021-2032) Figure 30. Global Parenteral PrEP Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Parenteral PrEP Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Parenteral PrEP Sales Market Share by Type (2021-2032) Figure 33. Global Parenteral PrEP Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Parenteral PrEP Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Parenteral PrEP Revenue Market Share by Application (2021-2032) Figure 36. Global Parenteral PrEP Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Parenteral PrEP Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Parenteral PrEP Sales Market Share by Application (2021-2032) Figure 39. North America Parenteral PrEP Revenue Share by Type (2021-2032) Figure 40. North America Parenteral PrEP Sales Share by Type (2021-2032) Figure 41. North America Parenteral PrEP Revenue Share by Application (2021-2032) Figure 42. North America Parenteral PrEP Sales Share by Application (2021-2032) Figure 43. North America Parenteral PrEP Revenue Share by Country (2021-2032) Figure 44. North America Parenteral PrEP Sales Share by Country (2021-2032) Figure 45. Europe Parenteral PrEP Revenue Share by Type (2021-2032) Figure 46. Europe Parenteral PrEP Sales Share by Type (2021-2032) Figure 47. Europe Parenteral PrEP Revenue Share by Application (2021-2032) Figure 48. Europe Parenteral PrEP Sales Share by Application (2021-2032) Figure 49. Europe Parenteral PrEP Revenue Share by Country (2021-2032) Figure 50. Europe Parenteral PrEP Sales Share by Country (2021-2032) Figure 51. China Parenteral PrEP Revenue Share by Type (2021-2032) Figure 52. China Parenteral PrEP Sales Share by Type (2021-2032) Figure 53. China Parenteral PrEP Revenue Share by Application (2021-2032) Figure 54. China Parenteral PrEP Sales Share by Application (2021-2032) Figure 55. Asia Parenteral PrEP Revenue Share by Type (2021-2032) Figure 56. Asia Parenteral PrEP Sales Share by Type (2021-2032) Figure 57. Asia Parenteral PrEP Revenue Share by Application (2021-2032) Figure 58. Asia Parenteral PrEP Sales Share by Application (2021-2032) Figure 59. Asia Parenteral PrEP Revenue Share by Country (2021-2032) Figure 60. Asia Parenteral PrEP Sales Share by Country (2021-2032) Figure 61. SAMEA Parenteral PrEP Revenue Share by Type (2021-2032) Figure 62. SAMEA Parenteral PrEP Sales Share by Type (2021-2032) Figure 63. SAMEA Parenteral PrEP Revenue Share by Application (2021-2032) Figure 64. SAMEA Parenteral PrEP Sales Share by Application (2021-2032) Figure 65. SAMEA Parenteral PrEP Revenue Share by Country (2021-2032) Figure 66. SAMEA Parenteral PrEP Sales Share by Country (2021-2032) Figure 67. Parenteral PrEP Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Parenteral PrEP Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Cabotegravir
  • Lenacapavir
  • Other
Applications
  • Subcutaneous Use
  • Intramuscular Use
Companies covered
  • Gilead Sciences
  • ViiV Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Parenteral PrEP Market by Type
  3. 1.2.1 Global Parenteral PrEP Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cabotegravir
  5. 1.2.3 Lenacapavir
  6. 1.2.4 Other
  7. 1.3 Parenteral PrEP Market by Application
  8. 1.3.1 Global Parenteral PrEP Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Subcutaneous Use
  10. 1.3.3 Intramuscular Use
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Parenteral PrEP Market Dynamics
  1. 2.1 Parenteral PrEP Industry Trends
  2. 2.2 Parenteral PrEP Industry Drivers
  3. 2.3 Parenteral PrEP Industry Opportunities and Challenges
  4. 2.4 Parenteral PrEP Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Parenteral PrEP Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Parenteral PrEP Revenue by Region
  3. 3.2.1 Global Parenteral PrEP Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Parenteral PrEP Revenue by Region (2021-2026)
  5. 3.2.3 Global Parenteral PrEP Revenue by Region (2027-2032)
  6. 3.2.4 Global Parenteral PrEP Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Parenteral PrEP Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Parenteral PrEP Sales by Region
  9. 3.4.1 Global Parenteral PrEP Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Parenteral PrEP Sales by Region (2021-2026)
  11. 3.4.3 Global Parenteral PrEP Sales by Region (2027-2032)
  12. 3.4.4 Global Parenteral PrEP Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Parenteral PrEP Revenue by Manufacturers
  2. 4.1.1 Global Parenteral PrEP Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Parenteral PrEP Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Parenteral PrEP Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Parenteral PrEP Sales by Manufacturers
  6. 4.2.1 Global Parenteral PrEP Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Parenteral PrEP Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Parenteral PrEP Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Parenteral PrEP Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Parenteral PrEP Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Parenteral PrEP Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Parenteral PrEP Manufacturers, Product Type & Application
  13. 4.7 Global Parenteral PrEP Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Parenteral PrEP Market CR5 and HHI
  16. 4.8.2 2025 Parenteral PrEP Tier 1, Tier 2, and Tier 3
5 Parenteral PrEP Market by Type
  1. 5.1 Global Parenteral PrEP Revenue by Type
  2. 5.1.1 Global Parenteral PrEP Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Parenteral PrEP Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Parenteral PrEP Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Parenteral PrEP Sales by Type
  6. 5.2.1 Global Parenteral PrEP Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Parenteral PrEP Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Parenteral PrEP Sales Market Share by Type (2021-2032)
  9. 5.3 Global Parenteral PrEP Price by Type
6 Parenteral PrEP Market by Application
  1. 6.1 Global Parenteral PrEP Revenue by Application
  2. 6.1.1 Global Parenteral PrEP Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Parenteral PrEP Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Parenteral PrEP Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Parenteral PrEP Sales by Application
  6. 6.2.1 Global Parenteral PrEP Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Parenteral PrEP Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Parenteral PrEP Sales Market Share by Application (2021-2032)
  9. 6.3 Global Parenteral PrEP Price by Application
7 Company Profiles
  1. 7.1 Gilead Sciences
  2. 7.1.1 Gilead Sciences Company Information
  3. 7.1.2 Gilead Sciences Business Overview
  4. 7.1.3 Gilead Sciences Parenteral PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Gilead Sciences Parenteral PrEP Product Portfolio
  6. 7.1.5 Gilead Sciences Recent Developments
  7. 7.2 ViiV Healthcare
  8. 7.2.1 ViiV Healthcare Company Information
  9. 7.2.2 ViiV Healthcare Business Overview
  10. 7.2.3 ViiV Healthcare Parenteral PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 ViiV Healthcare Parenteral PrEP Product Portfolio
  12. 7.2.5 ViiV Healthcare Recent Developments
8 North America
  1. 8.1 North America Parenteral PrEP Market Size by Type
  2. 8.1.1 North America Parenteral PrEP Revenue by Type (2021-2032)
  3. 8.1.2 North America Parenteral PrEP Sales by Type (2021-2032)
  4. 8.1.3 North America Parenteral PrEP Price by Type (2021-2032)
  5. 8.2 North America Parenteral PrEP Market Size by Application
  6. 8.2.1 North America Parenteral PrEP Revenue by Application (2021-2032)
  7. 8.2.2 North America Parenteral PrEP Sales by Application (2021-2032)
  8. 8.2.3 North America Parenteral PrEP Price by Application (2021-2032)
  9. 8.3 North America Parenteral PrEP Market Size by Country
  10. 8.3.1 North America Parenteral PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Parenteral PrEP Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Parenteral PrEP Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Parenteral PrEP Market Size by Type
  2. 9.1.1 Europe Parenteral PrEP Revenue by Type (2021-2032)
  3. 9.1.2 Europe Parenteral PrEP Sales by Type (2021-2032)
  4. 9.1.3 Europe Parenteral PrEP Price by Type (2021-2032)
  5. 9.2 Europe Parenteral PrEP Market Size by Application
  6. 9.2.1 Europe Parenteral PrEP Revenue by Application (2021-2032)
  7. 9.2.2 Europe Parenteral PrEP Sales by Application (2021-2032)
  8. 9.2.3 Europe Parenteral PrEP Price by Application (2021-2032)
  9. 9.3 Europe Parenteral PrEP Market Size by Country
  10. 9.3.1 Europe Parenteral PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Parenteral PrEP Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Parenteral PrEP Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Parenteral PrEP Market Size by Type
  2. 10.1.1 China Parenteral PrEP Revenue by Type (2021-2032)
  3. 10.1.2 China Parenteral PrEP Sales by Type (2021-2032)
  4. 10.1.3 China Parenteral PrEP Price by Type (2021-2032)
  5. 10.2 China Parenteral PrEP Market Size by Application
  6. 10.2.1 China Parenteral PrEP Revenue by Application (2021-2032)
  7. 10.2.2 China Parenteral PrEP Sales by Application (2021-2032)
  8. 10.2.3 China Parenteral PrEP Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Parenteral PrEP Market Size by Type
  2. 11.1.1 Asia Parenteral PrEP Revenue by Type (2021-2032)
  3. 11.1.2 Asia Parenteral PrEP Sales by Type (2021-2032)
  4. 11.1.3 Asia Parenteral PrEP Price by Type (2021-2032)
  5. 11.2 Asia Parenteral PrEP Market Size by Application
  6. 11.2.1 Asia Parenteral PrEP Revenue by Application (2021-2032)
  7. 11.2.2 Asia Parenteral PrEP Sales by Application (2021-2032)
  8. 11.2.3 Asia Parenteral PrEP Price by Application (2021-2032)
  9. 11.3 Asia Parenteral PrEP Market Size by Country
  10. 11.3.1 Asia Parenteral PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Parenteral PrEP Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Parenteral PrEP Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Parenteral PrEP Market Size by Type
  2. 12.1.1 SAMEA Parenteral PrEP Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Parenteral PrEP Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Parenteral PrEP Price by Type (2021-2032)
  5. 12.2 SAMEA Parenteral PrEP Market Size by Application
  6. 12.2.1 SAMEA Parenteral PrEP Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Parenteral PrEP Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Parenteral PrEP Price by Application (2021-2032)
  9. 12.3 SAMEA Parenteral PrEP Market Size by Country
  10. 12.3.1 SAMEA Parenteral PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Parenteral PrEP Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Parenteral PrEP Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Parenteral PrEP Value Chain Analysis
  2. 13.1.1 Parenteral PrEP Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Parenteral PrEP Production Mode & Process
  6. 13.2 Parenteral PrEP Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Parenteral PrEP Distributors
  9. 13.2.3 Parenteral PrEP Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst